Privia Health Group, Inc. (NASDAQ:PRVA) Receives Consensus Recommendation of “Buy” from Analysts
Privia Health Group, Inc. (NASDAQ:PRVA – Get Free Report) has received an average rating of “Buy” from the sixteen brokerages ...
Nasdaq11d
Privia Health price target raised to $27 from $24 at Truist
Truist raised the firm’s price target on Privia Health (PRVA) to $27 from $24 and keeps a Buy rating on the shares after its Q3 earnings beat. The company has had record new provider signings ...
Nasdaq19d
Privia Health (PRVA) Earnings Expected to Grow: Should You Buy?
The market expects Privia Health (PRVA) to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended September 2024. This widely-known consensus ...